Some patients benefit from combination therapy with both classes
There are six medications in the Incretin mimetic/GLP-1 analogues family: Generic or proper name Brand or trade name Exenatide (twice-daily injection) Byetta Exenatide (once-weekly injection) Bydureon Liraglutide (once-daily injection) Victoza Lixisenatide (once-daily injection) Lixumia Dulaglutide (once-weekly injection) Trulicity Semaglutide (once weekly injection) Ozempic Side effects All medication has side effects and you should check the patient information leaflet (PIL) supplied with your medication to see which side effects you might experience from your particular medication
"I was willing to take the risk because of how unhappy I was." Weinstein shared that she was on the medication for two or three months, where she experienced weight loss and more "side effects that didn't make [her] feel like [herself] or happy." She added, "I was the first one, a year ago, to judge
Healthcare professionals emphasize the importance of integrating pharmacotherapy with lifestyle changes for effective obesity treatment
But to lower costs, Medicare announced that Wegovy will be added to the agencys Inflation Reduction Act price controls
PMID: 28448947 Drucker DJ (2022): GLP-1 physiology informs the pharmacotherapy of obesity